0001104659-24-069618.txt : 20240607
0001104659-24-069618.hdr.sgml : 20240607
20240607160227
ACCESSION NUMBER: 0001104659-24-069618
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240605
FILED AS OF DATE: 20240607
DATE AS OF CHANGE: 20240607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nelson Steven Charles
CENTRAL INDEX KEY: 0002025906
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37704
FILM NUMBER: 241029189
MAIL ADDRESS:
STREET 1: 322 W 57TH ST
STREET 2: #33B
CITY: NEW YORK
STATE: NY
ZIP: 10020
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DarioHealth Corp.
CENTRAL INDEX KEY: 0001533998
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 452973162
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 322 W 57TH ST. #33B
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 972-4-770-6377
MAIL ADDRESS:
STREET 1: 322 W 57TH ST. #33B
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER COMPANY:
FORMER CONFORMED NAME: LabStyle Innovations Corp.
DATE OF NAME CHANGE: 20111101
4
1
tm2416654-2_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-06-05
0
0001533998
DarioHealth Corp.
DRIO
0002025906
Nelson Steven Charles
322 W 57TH ST, #33B
NEW YORK
NY
10011
0
1
0
0
Chief Commercial Officer
0
Stock Option (right to buy)
1.35
2024-06-05
4
A
0
500000
0
A
2034-06-05
Common Stock
500000
500000
D
Stock Option (right to buy)
1.35
2024-06-05
4
A
0
400000
0
A
2034-06-05
Common Stock
400000
400000
D
Stock Option (right to buy)
1.35
2024-06-05
4
A
0
1200000
0
A
2034-06-05
Common Stock
1350000
1350000
D
The options vest as follows: 500,00 shares vest over three years in three equal yearly amounts, subject to the Reporting Person's continued services to the Issuer on the applicable vesting date.
The options vest immediately upon achieving certain milestones relating to the achievement of revenues (on a U.S. generally accepted account principles basis) for the year ending December 31, 2024.
The options vest as follows: 400,000 shares begin to vest over three years in 12 equal quarterly amounts upon achieving certain milestones relating to the achievement of revenues (on a U.S. generally accepted account principles basis) for each of the years ending December 31, 2025, December 31, 2026 and December 31, 2027.
/s/ Steven Nelson
2024-06-07